SE

Septerna

SEPN
NASDAQHealth Care

Recent Patents

sepn
over 1 year ago

Filed a patent for "urea-containing agonists of orexin receptor 2" on Wed, July 5, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "urea-containing agonists of orexin receptor 2" on Wed, July 5, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis" on Tue, January 17, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "biaryl amide-containing agonists of orexin receptor 2" on Wed, February 8, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "mrgprx2 inhibitors and methods of use thereof" on Thu, April 27, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "substituted macrocyclic amine inhibitors of orexin receptor 2" on Thu, June 8, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis" on Thu, June 8, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "biaryl amide-containing agonists of orexin receptor 2" on Fri, July 21, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "mrgprx2 inhibitors and methods of use thereof" on Fri, October 27, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "mrgprx2 inhibitors and methods of use thereof" on Tue, December 26, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis" on Fri, May 5, 2023

New US Patent
sepn
over 1 year ago

Filed a patent for "compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis" on Fri, August 11, 2023

New US Patent